Charité is one of the largest university hospitals in Europe. Physicians and researchers deliver all of our clinical care, research, and teaching of the highest international standard. Charité proudly lays claim to more than half of all German Nobel Prize winners in Physiology or Medicine, including Emil von Behring, Robert Koch, and Paul Ehrlich. Charité is internationally renowned for its excellence in teaching and training. Charité – Universitätsmedizin Berlin represents a single medical faculty, which serves both Humboldt Universtität zu Berlin and Freie Universität Berlin. Charité extends over four campuses and has close to 100 different Departments and Institutes, which make up 17 different Charité Centers. Having marked its 300th anniversary in 2010, Charité is now one of the largest employers in Berlin, employing 13,200 staff (or 17,100 if including its subsidiaries), and with a total annual turnover of €1.6 billion.
In addition to its role in research and teaching, the Hospital's fundamental mission also includes patient care and treatment. With 660,000 outpatient cases and approximately 140,000 inpatient cases a year, Charité treats more patients than any other university hospital in Germany and, as a result, can draw on a wealth of experience and expertise.
This section provides an overview of the treatments and services offered. We hope this will allow you to find answers to some of your main questions and concerns. Should you have any questions at all, please do not hesitate to contact us. Our staff will be pleased to help.
Almost 7,000 students are currently enrolled in degree courses at Charité – Universitätsmedizin Berlin. They are being prepared to contribute to the future of medicine through research and clinical practice and offer the general public the highest-quality health care possible.
At Charité, students can get involved in student councils and committees, enabling them to have their say in the continuous development of teaching and learning. Some of the most significant contributions include introducing the Revised Medical Curriculum in 1999 and the New Revised Medical Curriculum in 2010.
Innovative capacity and responsible governance, for the benefit of patients and society - these are the central tenets behind all of Charité's research endeavors. At Charité, approximately 3,700 researchers are actively engaged in developing pioneering innovations in the field of medicine. Committed to the highest quality and sustainability standards, they work across 1,000 projects, working groups, and collaborative projects. There is a particular focus on the interface between primary and patient-oriented research, which fosters interdisciplinary collaborations with national and international partners. Harnessing this approach's potential is of particular importance to Charité, given that the most significant scientific developments are likely to arise from interdisciplinary cooperation.
Given the increasing complexity of today's research questions, research successes and new developments are likely to arise primarily due to interdisciplinary and international collaborations. Charité pursues a wide range of cooperative projects, particularly those promoting the mutual exchange of findings from basic biomedical research, clinical research, and clinical application. While committed to national and international research and growing its reputation on both the national and international stage, Charité remains true to its roots. Charité is very much the heart of Berlin-based health care research as well as its driving force. Developed in cooperation with the Max Delbrück Center for Molecular Medicine (MDC), the Berlin Institute of Health (BIH) continues to expand, offering a unique systems medicine approach in Germany.
Traditionally, Charité has been involved in the training of doctors and dentists. However, the university now also offers a Bachelor's Degree in Health Care Sciences and eleven Master's Degrees that prepare students for managerial roles within the health care sector.
Medical students who started their first year of medicine at Charité in the fall of 2010/11 were enrolled in the New Revised Medical Curriculum program. Before the winter semester 2010/11, medical students had the option of enrolling in either the Traditional Medical Curriculum or the Revised Medical Curriculum.
Since the New Revised Medical Curriculum introduction, the Traditional Medical Curriculum has no longer be available to new students at Charité. However, the Traditional degree program is still available at many of the other medical schools in Germany. Throughout Germany, the program is strictly regulated by the Licensing Regulations for Physicians, ensuring consistency in the content and teaching of pre-clinical and clinical medicine and the examinations (Staatsexamen) taken at the end of each of these sections of the course.
In the winter semester 1999/2000, Charité began to offer students the option of enrolling on either the Revised Medical Curriculum (Reformstudiengang, or RSM) or the Traditional Medical Curriculum. The addition of this new curriculum was supported by the Federal Ministry of Education and Research and other funding institutions. The aim of running both programs concurrently was to determine how internationally successful, multidisciplinary, problem-oriented medical courses might be integrated into the German educational system. The results led to many elements of the First Revised Medical Curriculum program being adopted as part of the current Revised Medical Curriculum, which has been in place since the winter semester of 2010/2011. The Revised Medical Curriculum program was withdrawn, with its successes celebrated as part of an expert symposium entitled "From Teaching to Learning" (Vom Lehren zum Lernen), held on 11th July 2015.
